DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.42
-0.35 (-5.17%)
Apr 1, 2026, 4:00 PM EDT - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $345.93 million as of April 1, 2026. Its market cap has increased by 54.92% in one year.
Market Cap
345.93M
Enterprise Value
286.28M
1-Year Change
54.92%
Ranking
Category
Stock Price
$6.42
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $345.93M, an increase of 842.58%. That is a compound annual growth rate of 35.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 345.90M | -16.55% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 375.50M |
| Armata Pharmaceuticals | 375.12M |
| XOMA Royalty | 374.03M |
| Invivyd | 367.37M |
| Autolus Therapeutics | 367.28M |
| Monopar Therapeutics | 366.74M |
| Enanta Pharmaceuticals | 366.51M |
| Benitec Biopharma | 364.81M |